The Federal Drug Administration has updated its compliance guide on pre-approval drug inspection, and changes will affect data and analytical procedures included in regulatory filings. Included in the updates are new field reporting requirements as well as redefined cooperation and shared responsibility between the Office of Regulatory Affairs and the Center for Drug Evaluation and Research for determining and performing an inspection.
FDA releases updated guide on pre-approval drug inspections
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.